Estimate Recalculated Nov 1, 2024 02:24PM EST
Bong yKoh does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Shockwave Medical, Inc., KalVista Pharmaceuticals, Inc., CONSTELLATION PHARMACEUTICALS INC, Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., AveXis, Inc., ARCA biopharma, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Avalanche Biotechnologies, Inc..
Bong yKoh's CIK is 0001615979
2016 was Bong yKoh's most active year for acquiring shares with 2 total transactions. Bong yKoh's most active month to acquire stocks was the month of January. 2018 was Bong yKoh's most active year for disposing of shares, totalling 4 transactions. Bong yKoh's most active month to dispose stocks was the month of April. 2016 saw Bong yKoh paying a total of $0.00 for 26,496 shares, this is the most they've acquired in one year. In 2018 Bong yKoh cashed out on 32,961 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!